chemotherapy/necrosis

BACKGROUND OF THE INVENTION This invention relates to a composition suitable for administration to mammalian hosts as a therapeutic formulation. More particularly, this invention relates to a combination therapy for free-radical bodily damage employing a lymphokine or cytotoxin such as tumor

This invention relates to tumor necrosis factors (TNF) and to compounds having enhanced cytotoxic or cytostatic activity for transformed cells. More particularly, the invention relates to a process for producing tumor necrosis factor-like polypeptides. Most particularly, this invention relates to

TECHNICAL FIELD The invention relates to treatment of tumors in animal subjects, including humans. The efficacy of the immunopotentiating therapy of the invention depends on the formation of macrophages specifically cytotoxic for tumor cells by virtue of previous destruction of some of the tumor

FIELD The present disclosure relates generally to immunotherapy and, more specifically, to therapeutic methods and compositions for treating tumors and pathogen infected tissues. BACKGROUND Harnessing the power of the immune system to treat chronic infectious diseases or cancer is a major goal of

This invention relates to the treatment of injury, especially injury resulting from radiation or chemotherapy. In particular, it relates to the amelioration of injury to otherwise healthy tissue concomitant with the treatment of cancers and other proliferative disorders, and in the course of bone

This invention relates to the treatment of injury, especially injury resulting from radiation or chemotherapy. In particular, it relates to the amelioration of injury to otherwise healthy tissue concomitant with the treatment of cancers and other proliferative disorders, and in the course of bone

FIELD OF THE INVENTION The present invention relates to therapeutic method and apparatus, and specifically to frequency selective radiation therapy for cancer. BACKGROUND OF THE INVENTION In the treatment of tumors by ionizing radiation, x-rays or gamma rays are particularly used. The ideal in

FIELD OF THE INVENTION The present invention relates to therapeutic methods and apparatus, and specifically to frequency selective radiation therapy for cancer. BACKGROUND OF THE INVENTION In the treatment of tumors by ionizing radiation, x-rays or gamma rays are particularly used. The ideal in

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the treatment of radiation- and/or chemotherapy-induced injuries. More particularly, the present invention relates to a method and pharmaceutical composition for increasing therapeutic gain in radiotherapy and

FIELD OF THE INVENTION The present invention relates generally to immunotherapy and, more specifically, to therapeutic methods and compositions for treating tumors and pathogen infected tissues. BACKGROUND OF THE INVENTION Harnessing the power of the immune system to treat chronic infectious

FIELD OF THE INVENTION The present invention relates generally to immunotherapy and, more specifically, to therapeutic methods and compositions for treating tumors and pathogen infected tissues. BACKGROUND OF THE INVENTION Harnessing the power of the immune system to treat chronic infectious

BACKGROUND OF THE INVENTION The present invention relates to pharmaceutically acceptable salts of an amide substituted indazole which are inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), previously known as poly(ADP-ribose)synthase and poly(ADP-ribosyl)transferase. The compounds of the

CROSS-REFERENCE TO RELATED APPLICATIONS This application is the national stage of International Application No. PCT/BE2008/000099, filed Nov. 26, 2008, which claims benefit of UK Patent Application No. GB0723124.4, filed Nov. 26, 2007. FIELD OF THE INVENTION The present invention concerns a